Klaus Elenius
15PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Dec 24, 2025
Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.Veera K Ojala, Sini Ahonen, Sara Peltola
|Jul 24, 2025
Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes.Katri Vaparanta, Zejia Song, Iman Farahani
|Apr 25, 2025
Novel Genetic Risk Variants Associated with Oral Tongue Squamous Cell Carcinoma.Rayan Nikkilä, Antti Mäkitie, Heikki Joensuu
|Jun 17, 2024
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.Majid Momeny, Mari Tienhaara, Mukund Sharma
|Jun 12, 2024
Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth In Vivo.Meija Honkanen, Elli Narvi, Veera K Ojala
|May 28, 2024
Trans-activating mutations of the pseudokinase ERBB3.Marika K A Koivu, Deepankar Chakroborty, Tomi T Airenne
Pageof 3
Frequent Collaborators
4 joint publications
Ilkka Paatero
4 joint publications
Katri Vaparanta
3 joint publications
Veera K Ojala
3 joint publications
Johannes A Merilahti
3 joint publications
Mark S Johnson
3 joint publications
Anne Jokilammi
3 joint publications
Kari J Kurppa
2 joint publications
Marika K A Koivu
1 joint publications
Deepankar Chakroborty
1 joint publications
Denis Tvorogov
